Thomas J. Schuetz insider trades: Compass Therapeutics (CMPX) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Thomas reports to the SEC
Open-market buys and sales
25 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 27, 2025 | CMPX | ↑ Buy | 10,000 | $2.11 | $21K | Direct | May 27, 2025 (0d) |
| Mar 10, 2023 | CMPX | ↑ Buy | 10,000 | $3.37 | $34K | Direct | Mar 10, 2023 (0d) |
| Feb 27, 2023 | CMPX | ↑ Buy | 20,000 | $3.98 | $80K | Direct | Feb 27, 2023 (0d) |
| Feb 15, 2023 | CMPX | ↑ Buy | 20,000 | $3.86 | $77K | Direct | Feb 15, 2023 (0d) |
| Jan 31, 2023 | CMPX | ↑ Buy | 20,000 | $4.05 | $81K | Direct | Jan 31, 2023 (0d) |
| Jan 24, 2023 | CMPX | ↑ Buy | 20,000 | $4.19 | $84K | Direct | Jan 24, 2023 (0d) |
| Sep 28, 2022 | CMPX | ↑ Buy | 10,000 | $2.32 | $23K | Direct | Sep 28, 2022 (0d) |
| Sep 26, 2022 | CMPX | ↑ Buy | 15,000 | $2.27 | $34K | Direct | Sep 27, 2022 (1d) |
| Sep 7, 2022 | CMPX | ↑ Buy | 15,000 | $3.03 | $45K | Direct | Sep 8, 2022 (1d) |
| Sep 1, 2022 | CMPX | ↑ Buy | 15,000 | $2.83 | $42K | Direct | Sep 1, 2022 (0d) |
| Aug 17, 2022 | CMPX | ↑ Buy | 15,000 | $3.05 | $46K | Direct | Aug 17, 2022 (0d) |
| Aug 10, 2022 | CMPX | ↑ Buy | 15,000 | $2.64 | $40K | Direct | Aug 10, 2022 (0d) |
| Aug 1, 2022 | CMPX | ↑ Buy | 15,000 | $2.58 | $39K | Direct | Aug 2, 2022 (1d) |
| Jun 21, 2022 | CMPX | ↑ Buy | 20,000 | $2.80 | $56K | Direct | Jun 21, 2022 (0d) |
| Jun 16, 2022 | CMPX | ↑ Buy | 20,000 | $2.34 | $47K | Direct | Jun 17, 2022 (1d) |
| Jun 13, 2022 | CMPX | ↑ Buy | 30,000 | $2.29 | $69K | Direct | Jun 13, 2022 (0d) |
| Jun 6, 2022 | CMPX | ↑ Buy | 30,000 | $2.83 | $85K | Direct | Jun 7, 2022 (1d) |
| Jun 1, 2022 | CMPX | ↑ Buy | 20,000 | $3.03 | $61K | Direct | Jun 1, 2022 (0d) |
| May 26, 2022 | CMPX | ↑ Buy | 20,000 | $3.04 | $61K | Direct | May 26, 2022 (0d) |
| May 23, 2022 | CMPX | ↑ Buy | 18,355 | $2.72 | $50K | Direct | May 24, 2022 (1d) |
| May 17, 2022 | CMPX | ↑ Buy | 20,215 | $2.47 | $50K | Direct | May 17, 2022 (0d) |
| May 10, 2022 | CMPX | ↑ Buy | 27,836 | $1.80 | $50K | Direct | May 10, 2022 (0d) |
| Jun 19, 2020 | NONE | ↑ Buy | 97,431 | $5.00 | $487K | Direct | Jun 23, 2020 (4d) |
| Mar 15, 2016 | RLYP | ↑ Buy | 30,000 | $13.39 | $402K | Direct | Mar 16, 2016 (1d) |
| Jun 11, 2015 | RLYP | ↓ Sell | 1,000 | $34.57 | $35K | Direct | Jun 15, 2015 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CMPX insiders
Open-market trades in the last 12 months
About Thomas J. Schuetz's insider trades
Thomas J. Schuetz is Chief Executive Officer at Compass Therapeutics (CMPX). Since Jun 11, 2015, Thomas has reported 24 open-market purchases worth $2.1M and 1 sale worth $35K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (16 filings), shares withheld for taxes (7 filings), shares returned to the company (2 filings), other transactions (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CMPX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.